Video

Dr Shauntice Allen Explains Community-Level Factors Contributing to Cancer Disparities

Until the underlying community health factors like poverty and education are addressed, disparities in cancer outcomes will persist, according to Shauntice Allen, PhD, assistant professor in the University of Alabama at Birmingham School of Public Health. She also discussed how health systems and providers can contribute to efforts to improve community health.

Until the underlying community health factors like poverty and education are addressed, disparities in cancer outcomes will persist, according to Shauntice Allen, PhD, assistant professor in the University of Alabama at Birmingham School of Public Health. She also discussed how health systems and providers can contribute to efforts to improve community health.

Transcript (slightly modified)

How do community-level health factors contribute to disparities in cancer care?

Community-level health factors, so things like poverty, lack of transportation, educational attainment, all of those things have a great deal of impact on cancer health disparities. Personally, I think that until we address those issues in a very meaningful way, we’re going to continue to see the disparities that we see.

How can healthcare providers and health systems work as partners in improving community health?

I think first, by really understanding that it is all of our jobs to address disparities, not only just in cancer, but in any kind of chronic disease issue. Then, being really open and willing to actually say: This is the lane that I know. This is what I know how to do. I may not be the best person in terms of outreach, but let me figure out who it is that I can partner with to help.

I really think it’s a kind of holistic approach that we need to take in terms of ensuring that providers and health systems not only are talking to each other and paying attention to patient care, but also thinking about and anticipating what those needs are of patients and the communities that they serve. We honestly all have a role to play in that.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo